Evidence map›Paper›PMID 42634671›Full record

ArticleCancer innovation2026

Global Burden and Temporal Trends of Brain and Central Nervous System Tumors in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 2021.

Zhaoyang Feng, Yu Su, Lin Yang, Kaiwen Deng, Jianmin Wang, Jiao Zhang, Fei Liu, Dongyang Wang, Yuyan Liang, Wei Wang and 4 more

Abstract read
In one paragraph

Article in Cancer innovation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zhaoyang FengDepartment of Neurosurgery Beijing Tiantan Hospital, Capital Medical University Beijing China.ORCID https://orcid.org/0009-0005-4781-2780
Yu SuSchool of Public Health, Capital Medical University Beijing China.
Lin YangDepartment of Hospital-Acquired Infection Control Beijing Jishuitan Hospital Beijing China.
Kaiwen DengDepartment of Neurosurgery Beijing Tiantan Hospital, Capital Medical University Beijing China.
Jianmin WangClinical Oncology School of Fujian Medical University Fujian Cancer Hospital Fuzhou China.
Jiao ZhangCancer and Hematology Center Texas Children's Hospital Houston Texas USA.
Fei LiuDepartment of Neurosurgery Beijing Tiantan Hospital, Capital Medical University Beijing China.
Dongyang WangDepartment of Neurosurgery Beijing Tiantan Hospital, Capital Medical University Beijing China.
Yuyan LiangLaboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China.
Wei WangLaboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China.
Xiaoguang QiuDepartment of Radiotherapy Beijing Tiantan Hospital, Capital Medical University Beijing China.
Tao JiangDepartment of Neurosurgery Beijing Tiantan Hospital, Capital Medical University Beijing China.
Yu TianSchool of Public Health, Capital Medical University Beijing China.
Hailong LiuDepartment of Radiotherapy Beijing Tiantan Hospital, Capital Medical University Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Central nervous system (CNS) tumors pose major global health challenges. Previous studies often assessed all-age populations without focusing on children and adolescents. We analyzed the burden and temporal trends of CNS tumors among individuals aged < 20 years from 1990 to 2021, with projections to 2036. Methods: Data were obtained from the Global Burden of Disease Study 2021, including annual incidence, mortality, and disability-adjusted life years (DALYs) for brain and CNS tumors. Regions were classified by Socio-demographic Index (SDI) to examine associations between burden and development. Temporal trends were analyzed using the age-period-cohort (APC) model and future projections via the Bayesian APC model. Results: In 2021, an estimated 40,534.53 (95% uncertainty interval [UI]: 33,345.94-49,609.04) new cases of brain and CNS tumors occurred worldwide. The global age-standardized incidence rate (ASIR) was 1.54 (95% UI: 1.27-1.88), and the death rate (ASDR) was 0.76 (0.61-0.93) per 100,000. High-SDI regions showed the highest ASIR and ASDR, while lower-SDI regions faced growing burdens. Mortality and DALYs improved most in Greenland, Serbia, and China. The APC model showed a mild global decline in incidence ( Conclusions: Global CNS tumor burden declined but remains uneven. Enhanced prevention and healthcare access are needed, especially in low-SDI regions.

Indexed as

age‐period‐cohortbrain tumorschildglobal burden of diseaseincidencemortality

Identifiers

PMID42634671
PMCPMC13499956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.